Precede

Series-B+
precede.bio Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-B+
Last Announced Jan 12, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Precede

Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website precede.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @Precede_Bio (91 followers) Created on Jul 2023
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Milestone

    X account created (@Precede_Bio)

    91 followers

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Precede.

Funding History

1 Round
Series-B+ · Jan 12, 2026

Founders & Leadership

4

Matthew Freedman

Co-Founder

Work email & phone locked Unlock →

Rehan Verjee

Co-Founder, Chief Executive Officer, Board Director

Work email & phone locked Unlock →

Sylvan Baca

Co-Founder

Work email & phone locked Unlock →

Toni Choueiri

Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts